Autophagy: The missing link in diabetic neuropathy?

Medical Hypotheses

Volumn 86, Issue , 2016, Pages 120-128

  Yerra, Veera Ganesh ^a   Gundu, Chayanika ^a   Bachewal, Pragna ^a   Kumar, Ashutosh ^a  

^a NATIONAL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH NIPER   (India)

Author keywords

[No Author keywords available]

Indexed keywords

HEAT SHOCK TRANSCRIPTION FACTOR 1; MAMMALIAN TARGET OF RAPAMYCIN; PERIPHERAL MYELIN PROTEIN 22; REACTIVE OXYGEN METABOLITE; NERVE PROTEIN;

ARTICLE; AUTOPHAGOSOME; AUTOPHAGY; CHAPERONE-MEDIATED AUTOPHAGY; CONFORMATIONAL TRANSITION; DEGENERATIVE DISEASE; DEMYELINATION; DIABETIC NEUROPATHY; ELECTRON TRANSPORT; ENDOPLASMIC RETICULUM STRESS; ENDOSOME; HUMAN; HYPERGLYCEMIA; LYSOSOME; MACROAUTOPHAGY; MITOPHAGY; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PROTEIN AGGREGATION; PROTEIN DEGRADATION; PROTEIN FOLDING; UNFOLDED PROTEIN RESPONSE; BIOLOGICAL MODEL; METABOLISM; NERVE CELL; PATHOLOGY;

AUTOPHAGY; DIABETIC NEUROPATHIES; HUMANS; MODELS, BIOLOGICAL; NERVE TISSUE PROTEINS; NEURONS; OXIDATIVE STRESS;

EID: 84957436064     PISSN: 03069877     EISSN: 15322777     Source Type: Journal    
DOI: 10.1016/j.mehy.2015.11.004     Document Type: Article

References (110)

1. The 10 leading causes of death in the world, 2000 and 2012 2014, World Health Organization, Geneva.
2. Martin C.L., Albers J., Herman W.H., et al. Neuropathy among the diabetes control and complications trial cohort 8 years after trial completion. Diabetes Care 2006, 29:340-344.
3. Zimmet P. Preventing diabetic complications: a primary care perspective. Diabetes Res Clin Pract 2009, 84:107-116.
4. Ziegler D. Painful diabetic neuropathy: treatment and future aspects. Diab Metab Res Rev 2008, 24:S52-S57.
5. Baron R., Binder A., Wasner G. Neuropathic pain: diagnosis, pathophysiological mechanisms, and treatment. Lancet Neurol 2010, 9:807-819.
6. Zenker J., Ziegler D., Chrast R. Novel pathogenic pathways in diabetic neuropathy. Trends Neurosci 2013, 36:439-449.
7. Singh R., Kishore L., Kaur N. Diabetic peripheral neuropathy: current perspective and future directions. Pharmacol Res 2014, 80:21-35.
8. Forman M.S., Trojanowski J.Q., Lee V.M.Y. Neurodegenerative diseases: a decade of discoveries paves the way for therapeutic breakthroughs. Nat Med 2004, 10:1055-1063.
9. Mizushima N. Autophagy: process and function. Genes Dev 2007, 21:2861-2873.
10. Ravikumar B., Sarkar S., Davies J.E., et al. Regulation of mammalian autophagy in physiology and pathophysiology. Physiol Rev 2010, 90:1383-1435.
11. Wong E., Cuervo A.M. Autophagy gone awry in neurodegenerative diseases. Nat Neurosci 2010, 13:805-811.
12. Reichling D.B., Levine J.D. Pain and death: neurodegenerative disease mechanisms in the nociceptor. Ann Neurol 2011, 69:13-21.
13. Yang Z., Klionsky D.J. Eaten alive: a history of macroautophagy. Nat Cell Biol 2010, 12:814-822.
14. Mizushima N., Yoshimori T., Ohsumi Y. The role of Atg proteins in autophagosome formation. Annu Rev Cell Dev Biol 2011, 27:107-132.
15. Glick D., Barth S., Macleod K.F. Autophagy: cellular and molecular mechanisms. J Pathol 2010, 221:3-12.
16. Jung C.H., Ro S.-H., Cao J., Otto N.M., Kim D.-H. MTOR regulation of autophagy. FEBS Lett 2010, 584:1287-1295.
17. Nakatogawa H. Two ubiquitin-like conjugation systems that mediate membrane formation during autophagy. Essays Biochem 2013, 55:39-50.
18. Longatti A., Tooze S.A. Vesicular trafficking and autophagosome formation. Cell Death Differ 2009, 16:956-965.
19. Kaushik S., Cuervo A.M. Chaperone-mediated autophagy: a unique way to enter the lysosome world. Trends Cell Biol 2012, 22:407-417.
20. Majeski A.E., Dice J.F. Mechanisms of chaperone-mediated autophagy. Int J Biochem Cell Biol 2004, 36:2435-2444.
21. Cuervo A.M., Dice J.F. A receptor for the selective uptake and degradation of proteins by lysosomes. Science 1996, 273:501-503.
22. Agarraberes F.A., Dice J.F. A molecular chaperone complex at the lysosomal membrane is required for protein translocation. J Cell Sci 2001, 114:2491-2499.
23. Li W.-W., Li J., Bao J.-K. Microautophagy: lesser-known self-eating. Cell Mol Life Sci 2012, 69:1125-1136.
24. Eckersley L. Role of the Schwann cell in diabetic neuropathy. Int Rev Neurobiol 2002, 50:293-321.
25. Lee S., Notterpek L. Dietary restriction supports peripheral nerve health by enhancing endogenous protein quality control mechanisms. Exp Gerontol 2013, 48:1085-1090.
26. Hoozemans J.J.M., Scheper W. Endoplasmic reticulum: the unfolded protein response is tangled in neurodegeneration. Int J Biochem Cell Biol 2012, 44:1295-1298.
27. Davies M.J., Fu S., Wang H., Dean R.T. Stable markers of oxidant damage to proteins and their application in the study of human disease. Free Radical Biol Med 1999, 27:1151-1163.
28. Levine R.L., Moskovitz J., Stadtman E.R. Oxidation of methionine in proteins: roles in antioxidant defense and cellular regulation. IUBMB Life 2000, 50:301-307.
29. Marciniak S.J., Ron D. Endoplasmic reticulum stress signaling in disease. Physiol Rev 2006, 86:1133-1149.
30. Kim E.S., Isoda F., Kurland I., Mobbs C.V. Glucose-induced metabolic memory in schwann cells: prevention by PPAR agonists. Endocrinology 2013, 154:3054-3066.
31. Rabek J.P., Boylston Iii W.H., Papaconstantinou J. Carbonylation of ER chaperone proteins in aged mouse liver. Biochem Biophys Res Commun 2003, 305:566-572.
32. Zhang K., Kaufman R.J. The unfolded protein response A stress signaling pathway critical for health and disease. Neurology 2006, 66:S102-S109.
33. Queisser M.A., Yao D., Geisler S., et al. Hyperglycemia impairs proteasome function by methylglyoxal. Diabetes 2010, 59:670-678.
34. Hooper P.L., Hooper J.J. Loss of defense against stress: diabetes and heat shock proteins. Diab Technol Ther 2005, 7:204-208.
35. Padmalayam I. The heat shock response: its role in pathogenesis of type 2 diabetes and its complications, and implications for therapeutic intervention. Discov Med 2014, 18:29-39.
36. Hamilton R.T., Bhattacharya A., Walsh M.E., et al. Elevated protein carbonylation, and misfolding in sciatic nerve from db/db and Sod1-/-Mice: plausible link between oxidative stress and demyelination. PLoS ONE 2013, 8:e65725.
37. Negi G., Kumar A., Joshi R.P., Sharma S.S. Oxidative stress and Nrf2 in the pathophysiology of diabetic neuropathy: old perspective with a new angle. Biochem Biophys Res Commun 2011, 408:1-5.
38. Srinivasan S., Stevens M., Wiley J.W. Diabetic peripheral neuropathy: evidence for apoptosis and associated mitochondrial dysfunction. Diabetes 2000, 49:1932-1938.
39. Fernyhough P., Huang T.J., Verkhratsky A. Mechanism of mitochondrial dysfunction in diabetic sensory neuropathy. J Peripheral Nerv Sys 2003, 8:227-235.
40. Viader A., Golden J.P., Baloh R.H., Schmidt R.E., Hunter D.A., Milbrandt J. Schwann cell mitochondrial metabolism supports long-term axonal survival and peripheral nerve function. J Neurosci 2011, 31:10128-10140.
41. Areti A., Yerra V.G., Naidu V.G.M., Kumar A. Oxidative stress and nerve damage: role in chemotherapy induced peripheral neuropathy. Redox Biol 2014, 2:289-295.
42. Fernyhough P., Roy Chowdhury S.K., Schmidt R.E. Mitochondrial stress and the pathogenesis of diabetic neuropathy. Exp Rev Endocrinol Metabol 2010, 5:39-49.
43. Hinder L.M., Vincent A.M., Burant C.F., Pennathur S., Feldman E.L. Bioenergetics in diabetic neuropathy: what we need to know. J Peripheral Nerv Sys 2012, 17:10-14.
44. Russell J.W., Golovoy D., Vincent A.M., et al. High glucose-induced oxidative stress and mitochondrial dysfunction in neurons. FASEB J 2002, 16:1738-1748.
45. Kaushik S., Bandyopadhyay U., Sridhar S., et al. Chaperone-mediated autophagy at a glance. J Cell Sci 2011, 124:495-499.
46. Xiong Y., Contento A.L., Nguyen P.Q., Bassham D.C. Degradation of oxidized proteins by autophagy during oxidative stress in Arabidopsis. Plant Physiol 2007, 143:291-299.
47. Ravikumar B., Futter M., Jahreiss L., et al. Mammalian macroautophagy at a glance. J Cell Sci 2009, 122:1707-1711.
48. Mizushima N., Yamamoto A., Matsui M., Yoshimori T., Ohsumi Y. In vivo analysis of autophagy in response to nutrient starvation using transgenic mice expressing a fluorescent autophagosome marker. Mol Biol Cell 2004, 15:1101-1111.
49. Xilouri M., Brekk O.R., Landeck N., et al. Boosting chaperone-mediated autophagy in vivo mitigates α-synuclein-induced neurodegeneration. Brain 2013, 136:2130-2146.
50. Xin Qisheng, Díaz-Carretero Antonio, Gavathiotis Evripidis, Cuervo AM. Chemical modulation of chaperone-mediated autophagy for protection against neurodegeneration. In: Paper from 8th annual drug discovery for neurodegeneration conference; 2014.
51. Jin S.M., Youle R.J. PINK1-and Parkin-mediated mitophagy at a glance. J Cell Sci 2012, 125:795-799.
52. Santos R.X., Correia S.C., Carvalho C., Cardoso S., Santos M.S., Moreira P.I. Mitophagy in neurodegeneration: an opportunity for therapy?. Curr Drug Targets 2011, 12:790-799.
53. Giordano S., Darley-Usmar V., Zhang J. Autophagy as an essential cellular antioxidant pathway in neurodegenerative disease. Redox Biol 2014, 2:82-90.
54. Palikaras K., Tavernarakis N. Mitochondrial homeostasis: the interplay between mitophagy and mitochondrial biogenesis. Exp Gerontol 2014, 56:182-188.
55. Sekiguchi A., Kanno H., Ozawa H., Yamaya S., Itoi E. Rapamycin promotes autophagy and reduces neural tissue damage and locomotor impairment after spinal cord injury in mice. J Neurotrauma 2012, 29:946-956.
56. Ravikumar B., Vacher C., Berger Z., et al. Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease. Nat Genet 2004, 36:585-595.
57. Pan T., Kondo S., Zhu W., Xie W., Jankovic J., Le W. Neuroprotection of rapamycin in lactacystin-induced neurodegeneration via autophagy enhancement. Neurobiol Dis 2008, 32:16-25.
58. Renna M., Jimenez-Sanchez M., Sarkar S., Rubinsztein D.C. Chemical inducers of autophagy that enhance the clearance of mutant proteins in neurodegenerative diseases. J Biol Chem 2010, 285:11061-11067.
59. Choi A.M.K., Ryter S.W., Levine B. Autophagy in human health and disease. N Engl J Med 2013, 368:651-662.
60. Towns R., Kabeya Y., Yoshimori T., et al. Sera from patients with type 2 diabetes and neuropathy induce autophagy and colocalization with mitochondria in SY5Y cells. Autophagy 2005, 1:163-170.
61. Zhang X.-J., Chen S., Huang K.-X., Le W.-D. Why should autophagic flux be assessed?. Acta Pharmacol Sin 2013, 34:595-599.
62. Yang S., Xia C., Li S., Du L., Zhang L., Hu Y. Mitochondrial dysfunction driven by the LRRK2-mediated pathway is associated with loss of Purkinje cells and motor coordination deficits in diabetic rat model. Cell Death Dis 2014, 5:e1217.
63. Rangaraju S., Verrier J.D., Madorsky I., Nicks J., Dunn W.A., Notterpek L. Rapamycin activates autophagy and improves myelination in explant cultures from neuropathic mice. J Neurosci 2010, 30:11388-11397.
64. Kosacka J., Nowicki M., Blüher M., et al. Increased autophagy in peripheral nerves may protect Wistar Ottawa Karlsburg W rats against neuropathy. Exp Neurol 2013, 250:125-135.
65. Watanabe T., Nagase K., Chosa M., Tobinai K. Schwann cell autophagy induced by SAHA, 17-AAG, or clonazepam can reduce bortezomib-induced peripheral neuropathy. Br J Cancer 2010, 103:1580-1587.
66. Berliocchi L., Russo R., Maiaru M., Levato A., Bagetta G., Corasaniti M.T. Autophagy impairment in a mouse model of neuropathic pain. Mol Pain 2013, 7:83.
67. Marinelli S., Nazio F., Tinari A., et al. Schwann cell autophagy counteracts the onset and chronification of neuropathic pain. Pain 2014, 155:93-107.
68. Song F., Kou R., Zou C., Gao Y., Zeng T., Xie K. Involvement of autophagy in tri-ortho-cresyl phosphate-induced delayed neuropathy in hens. Neurochem Int 2014, 64:1-8.
69. Mohseni S. Autophagy in insulin-induced hypoglycaemic neuropathy. Pathology 2011, 43:254-260.
70. Xiao G. Autophagy and NF-κB: Fight for fate. Cytokine Growth Factor Rev 2007, 18:233-243.
71. Sauer R.T., Baker T.A. AAA+ proteases: ATP-fueled machines of protein destruction. Annu Rev Biochem 2011, 80:587-612.
72. Glickman M.H., Ciechanover A. The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction. Physiol Rev 2002, 82:373-428.
73. Marfella R., D'Amico M., Esposito K., et al. The ubiquitin-proteasome system and inflammatory activity in diabetic atherosclerotic plaques effects of rosiglitazone treatment. Diabetes 2006, 55:622-632.
74. Buckley D.L., Crews C.M. Small-molecule control of intracellular protein levels through modulation of the ubiquitin proteasome system. Angew Chem Int Ed 2014, 53:2312-2330.
75. Huang W., Yang C., Nan Q., et al. The proteasome inhibitor, MG132, attenuates diabetic nephropathy by inhibiting SnoN degradation in vivo and in vitro. BioMed Res Int 2014, 2014.
76. Al-Khalili L., de Castro Barbosa T., Östling J., et al. Proteasome inhibition in skeletal muscle cells unmasks metabolic derangements in type 2 diabetes. Am J Physiol Cell Physiol 2014, 307:C774-C787.
77. Baker T.A., Sauer R.T. ClpXP, an ATP-powered unfolding and protein-degradation machine. Biochim Biophys Acta (BBA)-Mol Cell Res 1823, 2012:15-28.
78. Venkatesh S., Lee J., Singh K., Lee I., Suzuki C.K. Multitasking in the mitochondrion by the ATP-dependent Lon protease. Biochim Biophys Acta (BBA)-Mol Cell Res 1823, 2012:56-66.
79. Campello S., Strappazzon F., Cecconi F. Mitochondrial dismissal in mammals, from protein degradation to mitophagy. Biochim Biophys Acta 1837, 2014:451-460.
80. Matsushima Y., Goto Y.-I., Kaguni L.S. Mitochondrial Lon protease regulates mitochondrial DNA copy number and transcription by selective degradation of mitochondrial transcription factor A (TFAM). Proc Natl Acad Sci 2010, 107:18410-18415.
81. Lee H., Chung K., Lee H., Lee K., Lim J., Song J. Downregulation of mitochondrial lon protease impairs mitochondrial function and causes hepatic insulin resistance in human liver SK-HEP-1 cells. Diabetologia 2011, 54:1437-1446.
82. Padrão A.I., Carvalho T., Vitorino R., et al. Impaired protein quality control system underlies mitochondrial dysfunction in skeletal muscle of streptozotocin-induced diabetic rats. Biochim Biophys Acta 1822, 2012:1189-1197.
83. Ngo J.K., Pomatto L.C., Davies K.J. Upregulation of the mitochondrial Lon Protease allows adaptation to acute oxidative stress but dysregulation is associated with chronic stress, disease, and aging. Redox Biol 2013, 1:258-264.
84. Baker M.J., Tatsuta T., Langer T. Quality control of mitochondrial proteostasis. Cold Spring Harb Perspect Biol 2011, 3:a007559.
85. Kotiadis V.N., Duchen M.R., Osellame L.D. Mitochondrial quality control and communications with the nucleus are important in maintaining mitochondrial function and cell health. Biochim Biophys Acta 2014, 1840:254-1265.
86. Sandireddy R., Yerra V.G., Areti A., Komirishetty P., Kumar A. Neuroinflammation and oxidative stress in diabetic neuropathy: futuristic strategies based on these targets. Int J Endocrinol 2014, 2014.
87. Fernyhough P. Mitochondrial Dysfunction in Diabetic Neuropathy: a Series of Unfortunate Metabolic Events. Curr DiabRep 2015, 15:1-10.
88. Galloway C.A., Yoon Y. What comes first, misshape or dysfunction? The view from metabolic excess. J Gen Physiol 2012, 139:455-463.
89. Mihaylova M.M., Shaw R.J. The AMPK signalling pathway coordinates cell growth, autophagy and metabolism. Nat Cell Biol 2011, 13:1016-1023.
90. Sarkar S., Floto R.A., Berger Z., et al. Lithium induces autophagy by inhibiting inositol monophosphatase. J. Cell Biol. 2005, 170:1101-1111.
91. Williams A., Sarkar S., Cuddon P., et al. Novel targets for Huntington's disease in an mTOR-independent autophagy pathway. Nat Chem Biol 2008, 4:295-305.
92. Lu J.-H., Tan J.-Q., Durairajan S.S.K., et al. Isorhynchophylline, a natural alkaloid, promotes the degradation of-synuclein in neuronal cells via inducing autophagy. Autophagy 2012, 8:98-108.
93. Rao M.V., McBrayer M.K., Campbell J., et al. Specific calpain inhibition by calpastatin prevents tauopathy and neurodegeneration and restores normal lifespan in Tau P301L Mice. J Neurosci 2014, 34:9222-9234.
94. Jeong J.-K., Moon M.-H., Lee Y.-J., Seol J.-W., Park S.-Y. Melatonin-induced autophagy protects against human prion protein-mediated neurotoxicity. J Pineal Res 2012, 53:138-146.
95. Pivtoraiko V.N., Harrington A.J., Mader B.J., et al. Low-dose bafilomycin attenuates neuronal cell death associated with autophagy-lysosome pathway dysfunction. J Neurochem 2010, 114:1193-1204.
96. Rose C., Menzies F.M., Renna M., et al. Rilmenidine attenuates toxicity of polyglutamine expansions in a mouse model of Huntington's disease. Hum Mol Gene 2010, 19:2144-2153.
97. Tizon B., Sahoo S., Yu H., et al. Induction of autophagy by cystatin C: a mechanism that protects murine primary cortical neurons and neuronal cell lines. PLoS One 2010, 5:e9819.
98. Steele J.W., Gandy S. Latrepirdine (Dimebon (R)), a potential Alzheimer therapeutic, regulates autophagy and neuropathology in an Alzheimer mouse model. Autophagy 2013, 9:617-618.
99. Zhang L., Liu C., Wu J., et al. Tubastatin A/ACY-1215 improves cognition in Alzheimer's Disease transgenic mice. J Alzheimer's Dis 2014, 41:1193-1205.
100. Ha J.-Y., Kim J.-S., Kim S.-E., Son J.H. Simultaneous activation of mitophagy and autophagy by staurosporine protects against dopaminergic neuronal cell death. Neurosci Lett 2014, 561:101-106.
101. Liu Y., Hettinger C.L., Zhang D., Rezvani K., Wang X., Wang H. Sulforaphane enhances proteasomal and autophagic activities in mice and is a potential therapeutic reagent for Huntington's disease. J Neurochem 2014, 129:539-547.
102. Wang C., Zhang X., Teng Z., Zhang T., Li Y. Downregulation of PI3K/Akt/mTOR signaling pathway in curcumin-induced autophagy in APP/PS1 double transgenic mice. Eur J Pharmacol 2014, 740:312-320.
103. Liao G., Cheung S., Galeano J., Ji A.X., Qin Q., Bi X. Allopregnanolone treatment delays cholesterol accumulation and reduces autophagic/lysosomal dysfunction and inflammation in Npc1-/- mouse brain. Brain Res 2009, 1270:140-151.
104. Moon J.-H., Lee J.-H., Park J.-Y., et al. Caffeine prevents human prion protein-mediated neurotoxicity through the induction of autophagy. Int J Mol Med 2014, 34:553-558.
105. Jang W., Kim H.J., Li H., et al. 1, 25-dyhydroxyvitamin D3 attenuates rotenone-induced neurotoxicity in SH-SY5Y cells through induction of autophagy. Biochem Biophys Res Commun 2014, 451:142-147.
106. Kruger U., Wang Y., Kumar S., Mandelkow E.-M. Autophagic degradation of tau in primary neurons and its enhancement by trehalose. Neurobiol Aging 2012, 33:2291-2305.
107. Wu H., Lu M.-H., Wang W., et al. Lamotrigine reduces β-site AβPP-cleaving enzyme 1 protein levels through induction of autophagy. J Alzheimer's Dis 2015, 46(4):863-876.
108. Lin T.-K., Chen S.-D., Chuang Y.-C., et al. Resveratrol partially prevents rotenone-induced neurotoxicity in dopaminergic SH-SY5Y cells through induction of heme oxygenase-1 dependent autophagy. Int J Mol Sci 2014, 15:1625-1646.
109. Büttner S., Broeskamp F., Sommer C., et al. Spermidine protects against α-synuclein neurotoxicity. Cell Cycle 2014, 13:3903-3908.
110. Zhang S., Gui X.-H., Huang L.-P., et al. Neuroprotective effects of β-asarone against 6-hydroxy dopamine-induced parkinsonism via JNK/Bcl-2/beclin-1 pathway. Mol Neurobiol 2014, 1-12.